The Broadmoor, Colorado Springs Colorado
October 5-7, 2023
Click on the exhibitor/sponsor logo to view more information on the organization's website.
|
Artelon is the leader in dynamic augmentation of tendon and ligament reconstruction. Specifically designed bio-textiles resiliently reinforce the repair of soft tissue: uniquely restoring native motion, resisting the degradation of reconstruction strength, and supporting tendon and ligament regeneration. |
|
NanoBone® Bone Graft is a clinically proven bone graft substitute that's unique in its ability to harness the body’s own capacity to heal bone. NanoBone consists of nanocrystalline hydroxyapatite dispersed in an amorphous silica gel matrix. It is designed to be used alone, no need to add autograft, BMA, or blood. After implantation, NanoBone creates an osteogenic matrix within 14 days leading to clinical and radiographic healing in as little as 8 weeks. Published clinical data show NanoBone outcomes are equivalent to autograft with fewer complications. NanoBone is available as SBX Putty, combining advanced bone repair with exceptional handling for the surgeon, and QD, containing SBX Putty in an applicator designed for quick delivery of graft in a controlled and precise manner. Artoss, Inc. has been distributing NanoBone Bone Graft products in the United States since 2015. |
|
We, at b-ONE, are committed to improving the experience of both patients and surgeons through innovative technologies. With our passion for advanced manufacturing, advanced material science, artificial intelligence and robotics, we relentlessly pursue ways to offer best in class healthcare solutions while increasing healthcare economic value. Our goal is to help more patients worldwide to gain their active lifestyle back with the best means humankind ever created-innovative technology. |
|
Cerapedics is an advanced orthobiologics company with i-FACTOR® Peptide Enhanced Bone Graft. Among 400+ spinal bone grafts on the market, spine surgeons can feel confident in choosing i-FACTOR Peptide Enhanced Bone Graft, backed by Level 1 human clinical data from an IDE study published in Spine and Neurosurgery. In this study, i-FACTOR demonstrated high fusion rates and statistical superiority vs. autograft in overall clinical success. One of only two Class III FDA-PMA approved spinal bone grafts, i-FACTOR is the leading evidence-based alternative powered by a molecule called P-15: Osteogenic Cell Binding PeptideTM. i-FACTOR is free of many safety risks seen with other products such asectopic bone formation and, on average, costs at least 30% less expensive than other drug-device combination products with spinal indications. |
|
Clarus is an after-hours and daytime call solution for medical practices. Our SaaS platform replaces a traditional operator service, removing the human error that comes with routing calls. This means providers only get the right calls, patients receive faster time-to-care, and office staff can view full documentation on call activity. |
|
Established in 1987, Clint Pharmaceuticals is an industry-leading provider of high-quality FDA-approved injectable pharmaceuticals. CPI is not a compounding pharmacy. Clint Pharmaceuticals also distributes interventional pain management procedural trays and needles, orthopedic soft goods, and radiation protection apparel to physician offices and medical clinics throughout the United States. |
|
At ITS., we stand for long-term, trusting relationships with our customers, suppliers, and development partners. Through our dedication to innovation and development, we continuously seek to improve and optimize products and techniques for trauma surgery. All ITS. plates are made from Titanium Grade 2, whereas the screws are made of a harder titanium alloy. This allows the plates to have only non-threaded holes, which all (apart from oblong holes) accept both non-locking and locking screws. |
|
SuperCable® Polymer Cerclage System with its “Iso-elastic” polymer cable offers improved fatigue strength while eliminating metal cable debris, which have been shown to contribute to elevated systemic metal debris load, bearing surface wear, and component loosening. Glove tears/sharps injury from sharp metal cable ends are also eliminated. Re-tensioning of applied cables is easily accomplished via the cable’s unique locking clasp mechanism. Available with Trochanteric Grips and Cable-Plates. CarboJet® CO2 Bone Preparation System deep cleans the bone bed in any cemented arthroplasty procedure with the aim of reducing aseptic loosening and improving implant longevity. Lipids are brought to the surface for easy removal resulting in improved cement penetration and interface strength. CarboJet also facilitates tourniquetless TKA, which can provide for reduced pain and post-op opioid use in female patients. CarboJet XF® is a new, fully disposable version of the system that eliminates the overhead associated with cleaning and resterilizing instruments and is popular both in the hospital and ASC settings. KineMatch® PFR is a CT generated, patient matched PFJ. Results at 11-year average follow-up demonstrate improved outcomes as compared to “off-the-shelf” implants. The CT based process allows for decoupling of the front and backside shape so that the backside precisely fits the subchondral bone while the frontside provides for proper groove depth and orientation. OR time can be greatly reduced due to the simplicity afforded by the custom fit. MD3TTM Tibial Tubercle Transfer System offers instrumentation for precise, multidirectional tibial tubercle transfers. The system provides increased precision, safety and construct stability in TTO procedures. Designed in conjunction with Alan C. Merchant, MD, the system revolutionizes the tibial tubercle transfer procedure. |
|
Medacta is specialized in the design, production, and distribution of innovative orthopedic products and surgical techniques, supporting surgeons with comprehensive and tailored programs of medical education. Medacta is committed to improving the care and well-being of patients focusing on healthcare sustainability. Medacta’s innovation, forged by close collaboration with expert surgeons, began with minimally invasive techniques and has evolved into personalized solutions for every patient. |
|
Vericel develops, manufactures, and markets autologous cell-based therapies for patients with serious diseases and conditions. The company markets MACI® (autologous cultured chondrocytes on porcine collagen membrane), a third generation autologous cellularized scaffold product that is indicated for the repair of single or multiple symptomatic, full-thickness cartilage defects of the adult knee, with or without bone involvement. |
| Educational Grant |
| Zimmer Biomet |